Article
Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.
Psychopharmacology - 1 Jan 2015
Bishop Jeffrey R, Reilly James L, Harris Margret S H, Patel Shitalben R, Kittles Rick, Badner Judith A, Prasad Konasale M, Nimgaonkar Vishwajit L, Keshavan Matcheri S, Sweeney John A
Abstract excerpt
RATIONALE: Type-3 metabotropic glutamate receptor gene (GRM3) single nucleotide polymorphisms (SNPs) have been associated with cognitive performance and prefrontal cortex brain activity in chronically treated schizophrenia patients. Whether these SNPs are associated with cognitive and symptom response to antipsychotic therapy has not been extensively evaluated. OBJECTIVES: The aim of the study was to examine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.